FendX Technologies Inc. is a nanotechnology company focused on developing products that reduce the transmission of pathogens, with a wide range of applications.
FendX has engaged Innovotech to provide a summary of the potential FDA regulatory pathway for its coated Foley catheter. This activity will support continued development of FendX’s technology being designed to reduce bacteria growth and infection risk: https://t.co/HPniHxFAzZ
FendX Technologies engages Galenvs Sciences to establish the manufacturing process for FendX’s liquid surface coating, including producing three pilot lots to assess consistency across batches — a key step toward commercialization.
NEWS RELEASE: https://t.co/HPniHxFAzZ
Our liquid coating is showing promising performance and durability, while our catheter coating aimed at reducing bacterial adhesion continues to advance. We’re expanding into digital health with an AI driven microbial contamination detection app: https://t.co/HPniHxFAzZ
FendX has signed a collaboration agreement with Aquaox, formalizing the first phase of work from their Nov 2025 MOU. They’ll assess feasibility and formulation of new antimicrobial agents for potential future products, says CEO Dr. Carolyn Myers: https://t.co/HPniHxFAzZ
FendX is attending the 3rd Annual Dealflow Discovery Conference, January 28-29, 2026. CEO Carolyn Myers will deliver a presentation and meet one-on-one with investors to discuss recent progress, plans for 2026 and investment opportunities.
In partnership with FendX, Dr. Sara Imani, a post-doctoral fellow at McMaster University, has received the Mitacs Innovation Award for advancing an antimicrobial surface coating.
LEARN MORE: https://t.co/1LHOKshWLK
FendX Technologies has signed an MOU with Aquaox to formulate eco-friendly pathogen-eliminating agents for FendX to develop new disinfectant products, expanding FendX’s pipeline and IP portfolio.
NEWS RELEASE: https://t.co/HPniHxFAzZ
CSE: FNDX | OTCQB: FDXTF | FSE: E8D
FendX has filed a provisional patent with the USPTO for a catheter coating that reduces microbial growth and improves patient comfort, strengthening its portfolio of infection-reducing technologies.
Provisional patent for an AI-powered app to detect pathogens in real time using a mobile device has been filed by FendX CEO Dr. Carolyn Myers.
NEWS RELEASE: https://t.co/HPniHxFAzZ
CSE: FNDX | OTCQB: FDXTF | FSE: E8D
“We are very encouraged by the continued successful performance of REPELWRAP™ film in real-world conditions,” said Dr. Carolyn Myers, our CEO. “These results support the promise of our technology, and we are now evaluating potential next steps in its development.”
FendX is featured in the June edition of the Canadian Securities Exchange Technology Issue! This spotlight highlights our innovative nanotechnology and the impact we’re making in the health and safety space.
READ PAGES 28 TO 31: https://t.co/imPquxc8LK
FendX Technologies has hired a branding expert to help develop and market its new eco-friendly sponge line, targeting global consumer and commercial markets.
NEWS RELEASE: https://t.co/HPniHxFAzZ
CSE: FNDX | OTCQB: FDXTF | FSE: E8D
FendX signs supply agreement with US BioSolutions for eco-friendly foam that is biodegradable, resistant to bacterial growth and free of toxic plasticizers to create various sponge products – tapping into a $1.96B North American household sponge market: https://t.co/HPniHxFAzZ
Update includes key milestones achieved since the last update, business development initiatives, and milestones planned for the remainder of 2025.
NEWS RELEASE: https://t.co/HPniHxFAzZ
FendX’s CEO will deliver a corporate presentation on Wednesday, January 29 at 2:30 pm and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy & investment opportunities: https://t.co/HPniHxFAzZ
FendX signs LOI to acquire IP and enter a supply agreement for eco-friendly, reusable sponge wipes, offering a sustainable alternative to traditional surface cleaning sponges.
NEWS RELEASE: https://t.co/HPniHxFAzZ
FendX Technologies has been granted its U.S. patent to protect REPELWRAP™ film, marking this its fifth patent issued, reinforcing FendX’s focus on building a robust IP portfolio.
NEWS RELEASE: https://t.co/HPniHxFAzZ
FendX Technologies has entered into a Letter of Intent with Sinelabs LLC, aiming to establish a non-exclusive sales and distribution partnership for FendX’s future surface protection products in the U.S. market.
NEWS RELEASE: https://t.co/HPniHxG8px